Every decade or so, there is a “new” epidemic declared. This time, the media are publishing numerous articles about newborns whose mothers have used prescription medications, specifically narcotics, during pregnancy.

 Actually, this is nothing new.

While the use of heroin has waxed and waned over the last several decades, the misuse of prescription drugs has been a constant. Granted, the rates are going up, and nurseries across the country are seeing relatively large numbers of infants going through abstinence due to their exposure to narcotics. But this is a problem that physicians working with pregnant women have been dealing with for many years. My work with a maternal and child health team in Nevada in 2012 and 2013 did not hold many surprises. But we did not expect to find 1,791 pregnant women who were using a medication without a prescription. The most commonly misused prescription medications were narcotics (pain-killers) ⎯ Vicodine®, Percocet® and Lortab;® antidepressants ⎯ Prozac® and Zoloft;® and benzodiazepines (anti-anxiety meds), primarily Xanax®.

A study last year in The Journal of the American Medical Association estimated that about 13,500 babies are born each year with symptoms that demonstrate maternal narcotic abuse, many times due to prescription medications. Babies with signs of withdrawal from narcotics look much like adults going through withdrawal: yawning, sneezing, irritability, high-pitched cry, jitteriness, sweating, vomiting, diarrhea, even seizures and respiratory distress. This occurs no matter what form the narcotic may take — whether it is heroin for intravenous injection, methadone used legally or illegally, or in the form of a prescription drug. Abuse can result in the physical dependence of both the mother and the fetus.

Many such infants stay in the hospital for several days or weeks while doctors use medications like methadone or morphine to provide symptomatic relief and wean them from the drugs that their mothers used. Withdrawal symptoms peak around six weeks of age and can persist for four to six months or longer. These infants also may demonstrate many of the same problems as infants prenatally exposed to other substances, including low birth weight, prematurity, muscle tone changes, and infant behavioral problems. Long-term studies have shown that the children’s ultimate intellectual development is normal, but the children do have ongoing difficulties with executive functioning deficits.

Non-narcotic medications, such as anti-depressants and benzodiazepines, present another problem because so little is known about their effects on the fetus. It is difficult to identify, and count, affected infants, so there are no reliable data as to how many pregnancies include misuse of these substances. In addition, there is very little information about the impact of these other medications either on short term or long-term outcome of the child, but a variety of reports have begun to examine these issues.

So where does this leave us?

If a woman needs a particular medication, such as an anti-depressant, she must work with her physician to find the appropriate dose, to monitor the pregnancy closely, and to be prepared to address the needs of the child at birth and long term. Physicians need to incorporate questions in prenatal care that ask about the use of medications, whether prescribed or not. Along with this, it is important to share the message that misuse of medications during pregnancy has long-term implications for the exposed child.

Dr. Chasnoff is author of the award-winning book, The Mystery of Risk.

About the Author

Ira J. Chasnoff, M.D.

Ira J. Chasnoff, M.D., is a Professor of Clinical Pediatrics at the University of Illinois College of Medicine in Chicago. His most recent work is The Mystery of Risk.

You are reading

Aristotle's Child

Medical Marijuana and Pregnancy

Should a doctor do a pregnancy test before prescribing marijuana to a woman?

Prenatal Drug Exposure and Disruption of Attachment

Attachment must travel a two-way street

Missing the Boat on Diagnosis

Why can't we get it right? Misdiagnosis of children with FASDs